Pigmentary findings in neurofibromatosis type 1-like syndrome (Legius syndrome): Potential diagnostic dilemmas

JAMA

Volumn 302, Issue 19, 2009, Pages 2150-2151

  Stevenson, David ^a   Viskochil, David ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL DOMINANT INHERITANCE; CAFE AU LAIT SPOT; CLINICAL FEATURE; DIAGNOSTIC VALUE; EDITORIAL; GENE DELETION; GENE MUTATION; HUMAN; LEGIUS SYNDROME; LENTIGO; NEUROFIBROMATOSIS TYPE 1 LIKE SYNDROME; NF1 GENE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; SKIN PIGMENTATION; SPRED1 GENE;

CAFE-AU-LAIT SPOTS; GENES, NEUROFIBROMATOSIS 1; GENETIC ASSOCIATION STUDIES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MUTATION; NEUROFIBROMATOSIS 1; PHENOTYPE; SYNDROME;

EID: 71749117156     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.1690     Document Type: Editorial

References (12)

1. Messiaen L, Yao S, Brems H, et al. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome. JAMA. 2009;302(19):2111-2118.
2. Online Mendelian Inheritance in Man. Legius syndrome. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=611431. Accessed October 22, 2009.
3. Brems H, Chmara M, Sahbatou M. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet. 2007;39(9):1120-1126. (Pubitemid 47340658)
4. Pasmant E, Sabbagh A, Hanna N, et al. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. J Med Genet. 2009;46(7):425-430.
5. Spurlock G, Bennett E, Chuzhanova N, et al. SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype. J Med Genet. 2009;46(7):431-437.
6. Pasmant E, Ballerini P, Lapillonne H, et al. SPRED1 disorder and predisposition to leukemia in children. Blood. 2009;114(5):1131.
7. Neurofibromatosis: conference statement: National Institutes of Health Consensus Development Conference. Arch Neurol. 1988;45(5):575-578.
8. Gutmann DH, Aylsworth A, Carey JC, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997;278(1):51-57. (Pubitemid 27274517)
9. Crowe FW. Axillary freckling as a diagnostic aid in neurofibromatosis. Ann Intern Med. 1964;61:1142-1143.
10. Stevenson DA, Viskochil DH, Schorry EK, et al. The use of anterolateral bowing of the lower leg in the diagnostic criteria for neurofibromatosis type 1. Genet Med. 2007;9(7):409-412.
11. Nyström AM, Ekvall S, Strömberg B, et al. A severe form of Noonan syndrome and autosomal dominant café-au-lait spots - evidence for different genetic origins. Acta Paediatr. 2009;98(4):693-698.
12. Upadhyaya M, Huson SM, Davies M, et al. An absence of cutaneous neurofibroma associated with a 3-bp in-frame deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet. 2007;80(1):140-151. (Pubitemid 46047657)